MS. NOLYN C NYATANGA DO
Prescription History 1518101708
Internal Medicine - Medical Oncology in Valley Stream, NY
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MS. NOLYN C NYATANGA DO, an active Medical Oncology specialist practicing in Valley Stream, NY. Our medical registry currently tracks 41 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 1,299 documented patient claims. Among these therapy options, the most frequently utilized medication is Anastrozole, which accounts for 117 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other NY PrescribersVs. NY Avg |
|---|---|---|---|
| Anastrozole | 117 | $18.65▼ below NY avg | ▲ More than typical |
About Anastrozole: Anastrozole is used to treat breast cancer in women after menopause. Show more ▾ Some breast cancers are made to grow faster by a natural hormone called estrogen. Anastrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. A nitrile and triazole derivative that acts as a selective nonsteroidal aromatase inhibitor. It is used in the treatment of ESTROGEN NUCLEAR RECEPTOR-positive breast cancer in postmenopausal women. In 2023, this provider wrote 117 Medicare prescriptions for Anastrozole, about 1.8 times the volume of the typical New York prescriber of this medication (64). Medicare paid an average of $18.65 per fill, versus $28.63 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 233 30-Day Fills standardized to 30-day supplies 6,990 Days of Medication total across all patients in 2023 | |||
| ProcritEpoetin Alfa | 109 | $3,417.05 | ▲ More than typical |
About Procrit: This medication is used to treat anemia (low red blood cell count) in people with long-term serious kidney disease (chronic kidney failure), people receiving zidovudine to treat HIV, and people receiving chemotherapy for some types of cancer (cancer that does Show more ▾ not involve the bone marrow or blood cells). It may also be used in anemic patients to reduce the need for blood transfusions before certain planned surgeries that have a high risk of blood loss (usually given with an anticoagulant/blood thinner medication such as warfarin to lower the risk of serious blood clots). Epoetin alfa works by signaling the bone marrow to make more red blood cells. This medication is very similar to the natural substance in your body (erythropoietin) that prevents anemia. This monograph is about the following epoetin alfa products: epoetin alfa and epoetin alfa-epbx. A recombinant glycosylated form of erythropoietin which stimulates the differentiation and proliferation of erythroid precursors. It is used for the treatment of ANEMIA associated with CHRONIC RENAL FAILURE in dialysis and predialysis patients. In 2023, this provider wrote 109 Medicare prescriptions for Procrit, about 4.2 times the volume of the typical New York prescriber of this medication (26). Medicare paid an average of $3,417.05 per fill, versus $2,038.77 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 109 30-Day Fills standardized to 30-day supplies 3,068 Days of Medication total across all patients in 2023 | |||
| EliquisApixaban | 86 | $788.65▼ below NY avg | ≈ Typical |
About Eliquis: Apixaban is used to prevent serious blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip/knee replacement surgery. Show more ▾ With atrial fibrillation, part of the heart does not beat the way it should. This can lead to blood clots forming, which can travel to other parts of your body (such as the lungs or legs) or increase your risk for stroke. In the United States, apixaban is also approved to treat certain types of blood clots (deep vein thrombosis-DVT, pulmonary embolus-PE) and to prevent them from forming again. Apixaban is an anticoagulant that works by blocking certain clotting proteins in your blood. In 2023, this provider wrote 86 Medicare prescriptions for Eliquis, about the same volume as the typical New York prescriber of this medication (78). Medicare paid an average of $788.65 per fill, versus $816.86 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 122 30-Day Fills standardized to 30-day supplies 3,564 Days of Medication total across all patients in 2023 | |||
| AkynzeoFosnetupitant/Palonosetron | 79 | $1,277.27 | ▲ More than typical |
About Akynzeo: This product is a combination of 2 medications: fosnetupitant and palonosetron. Show more ▾ It is used to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy). Fosnetupitant and palonosetron work by blocking natural substances in the body (such as substance P/neurokinin 1, serotonin) that cause vomiting. In 2023, this provider wrote 79 Medicare prescriptions for Akynzeo, about 2.3 times the volume of the typical New York prescriber of this medication (35). Medicare paid an average of $1,277.27 per fill, versus $1,205.79 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 79 30-Day Fills standardized to 30-day supplies 1,925 Days of Medication total across all patients in 2023 | |||
| Darzalex FasproDaratumumab-Hyaluronidase-Fihj | 66 | $14,230.83▼ below NY avg | ▲ More than typical |
About Darzalex Faspro: This medication is used to treat a certain type of cancer (multiple myeloma). Show more ▾ This medication contains 2 ingredients: daratumumab and hyaluronidase. Daratumumab belongs to a class of drugs known as monoclonal antibodies. It works by slowing or stopping the growth of cancer cells. Hyaluronidase is used to help the body absorb daratumumab, which helps it work better. This medication is also used to treat light chain (AL) amyloidosis. This monograph is about the following daratumumab/hyaluronidase products: daratumumab/hyaluronidase, daratumumab/hyaluronidase-fihj. In 2023, this provider wrote 66 Medicare prescriptions for Darzalex Faspro, about 3.5 times the volume of the typical New York prescriber of this medication (19). Medicare paid an average of $14,230.83 per fill, versus $18,941.83 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 66.9 30-Day Fills standardized to 30-day supplies 1,855 Days of Medication total across all patients in 2023 | |||
| Prednisone | 57 | $5.50▼ below NY avg | ▲ More than typical |
About Prednisone: Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Show more ▾ Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. In 2023, this provider wrote 57 Medicare prescriptions for Prednisone, about 1.3 times the volume of the typical New York prescriber of this medication (44). Medicare paid an average of $5.50 per fill, versus $6.20 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 57 30-Day Fills standardized to 30-day supplies 1,464 Days of Medication total across all patients in 2023 | |||
| AranespDarbepoetin Alfa In Polysorbat | 45 | $3,250.63▼ below NY avg | ≈ Typical |
About Aranesp: This medication is used to treat anemia (low red blood cell count) in people with long-term serious kidney disease (chronic kidney failure) and people receiving chemotherapy for some types of cancer (cancer that does not involve the bone marrow or blood cells). Show more ▾ Darbepoetin alfa also helps to reduce the need for blood transfusions. It works by signaling the bone marrow to make more red blood cells. This medication is very similar to the natural substance in your body (erythropoietin) that prevents anemia. A recombinant protein which stimulates ERYTHROPOIESIS used to treat ANEMIA. In 2023, this provider wrote 45 Medicare prescriptions for Aranesp, about 83% of the volume of the typical New York prescriber of this medication (54). Medicare paid an average of $3,250.63 per fill, versus $3,350.20 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 45 30-Day Fills standardized to 30-day supplies 912 Days of Medication total across all patients in 2023 | |||
| XgevaDenosumab | 40 | $3,209.56 | ▲ More than typical |
About Xgeva: Denosumab is used to treat bone loss (osteoporosis) in people who have a high risk of getting fractures. Show more ▾ Osteoporosis causes bones to become thinner and break more easily. Your chance of developing osteoporosis increases after menopause (in women), as you age, if someone in your family has osteoporosis, or if you take certain medications (such as prednisone) for long periods. This medication works by slowing bone loss to help maintain strong bones and reduce the risk of broken bones (fractures). Denosumab belongs to a class of drugs called monoclonal antibodies. It prevents certain cells in the body (osteoclasts) from breaking down bone. A humanized monoclonal antibody and an inhibitor of the RANK LIGAND, which regulates OSTEOCLAST differentiation and bone remodeling. It is used as a BONE DENSITY CONSERVATION AGENT in the treatment of OSTEOPOROSIS. In 2023, this provider wrote 40 Medicare prescriptions for Xgeva, about 1.3 times the volume of the typical New York prescriber of this medication (30). Medicare paid an average of $3,209.56 per fill, versus $2,901.97 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 40 30-Day Fills standardized to 30-day supplies 1,128 Days of Medication total across all patients in 2023 | |||
| ImbruvicaIbrutinib | 39 | $16,427.76 | ▲ More than typical |
About Imbruvica: This medication is used to treat certain cancers (such as mantle cell or marginal zone lymphoma, chronic lymphocytic leukemia/small lymphocytic lymphoma, Waldenstrom's macroglobulinemia). Show more ▾ Ibrutinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. Ibrutinib is also used to treat a certain problem that may occur after a stem cell transplant (chronic graft versus host disease). It works by weakening your body's defense system (immune system). In 2023, this provider wrote 39 Medicare prescriptions for Imbruvica, about 1.3 times the volume of the typical New York prescriber of this medication (31). Medicare paid an average of $16,427.76 per fill, versus $14,730.97 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 39 30-Day Fills standardized to 30-day supplies 1,092 Days of Medication total across all patients in 2023 | |||
| MvasiBevacizumab-Awwb | 38 | $6,224.44▼ below NY avg | ▲ More than typical |
About Mvasi: This medication is a man-made antibody (IgG1) used to treat various types of cancer. Show more ▾ This drug works by blocking a certain protein (vascular endothelial growth factor-VEGF) thereby decreasing the blood supply to the tumor and slowing tumor growth. This monograph is about the following bevacizumab products: bevacizumab, bevacizumab-awwb, bevacizumab-bvzr, and bevacizumab-maly. An anti-VEGF humanized murine monoclonal antibody. It inhibits VEGF RECEPTORS and helps to prevent PATHOLOGIC ANGIOGENESIS. In 2023, this provider wrote 38 Medicare prescriptions for Mvasi, about 2.2 times the volume of the typical New York prescriber of this medication (17). Medicare paid an average of $6,224.44 per fill, versus $7,973.79 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 38 30-Day Fills standardized to 30-day supplies 819 Days of Medication total across all patients in 2023 | |||
| Neulasta OnproPegfilgrastim | 36 | $7,059.79▼ below NY avg | ▲ More than typical |
About Neulasta Onpro: Pegfilgrastim is a man-made version of a certain natural substance made by your body. Show more ▾ It is used to help your body make more white blood cells. White blood cells are important to help you fight off infections. Pegfilgrastim is given to people whose ability to make white blood cells is reduced due to chemotherapy. Some brands may also be used to increase white blood cells after exposure to large amounts of radiation. This monograph is about the following pegfilgrastim products: pegfilgrastim, pegfilgrastim-apgf, pegfilgrastim-cbqv, pegfilgrastim-jmdb, pegfilgrastim-bmez, pegfilgrastim-fpgk, and pegfilgrastim-pbbk. In 2023, this provider wrote 36 Medicare prescriptions for Neulasta Onpro, about 1.4 times the volume of the typical New York prescriber of this medication (25). Medicare paid an average of $7,059.79 per fill, versus $7,342.90 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 36 30-Day Fills standardized to 30-day supplies 777 Days of Medication total across all patients in 2023 | |||
| Abiraterone Acetate | 34 | $5,557.68 | ≈ Typical |
About Abiraterone Acetate: This medication is used to treat prostate cancer. Show more ▾ Abiraterone belongs to a class of drugs known as anti-androgens (anti-testosterone). Testosterone, a natural hormone, helps prostate cancer to grow and spread. Abiraterone works by blocking the production of testosterone, thereby slowing the growth and spread of prostate cancer. This medication should not be given to women or children. An androstene derivative that inhibits STEROID 17-ALPHA-HYDROXYLASE and is used as an ANTINEOPLASTIC AGENT in the treatment of metastatic castration-resistant PROSTATE CANCER. In 2023, this provider wrote 34 Medicare prescriptions for Abiraterone Acetate, about 77% of the volume of the typical New York prescriber of this medication (44). Medicare paid an average of $5,557.68 per fill, versus $3,990.89 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 34 30-Day Fills standardized to 30-day supplies 1,020 Days of Medication total across all patients in 2023 | |||
| Tamoxifen Citrate | 34 | $18.29▼ below NY avg | ≈ Typical |
About Tamoxifen Citrate: Tamoxifen is used to treat breast cancer. Show more ▾ It is also used to reduce the chances of breast cancer in high-risk patients. This medication can block the growth of breast cancer. It works by interfering with the effects of estrogen in the breast tissue. One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM. In 2023, this provider wrote 34 Medicare prescriptions for Tamoxifen Citrate, about the same volume as the typical New York prescriber of this medication (31). Medicare paid an average of $18.29 per fill, versus $35.81 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 62 30-Day Fills standardized to 30-day supplies 1,845 Days of Medication total across all patients in 2023 | |||
| Mirtazapine | 33 | $12.78▼ below NY avg | ▼ Less than typical |
About Mirtazapine: Mirtazapine is used to treat depression. Show more ▾ It improves mood and feelings of well-being. Mirtazapine is an antidepressant that works by restoring the balance of natural chemicals (neurotransmitters) in the brain. A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders. In 2023, this provider wrote 33 Medicare prescriptions for Mirtazapine, about 61% of the volume of the typical New York prescriber of this medication (54). Medicare paid an average of $12.78 per fill, versus $20.97 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 37 30-Day Fills standardized to 30-day supplies 1,080 Days of Medication total across all patients in 2023 | |||
| Letrozole | 31 | $24.56▼ below NY avg | ▼ Less than typical |
About Letrozole: This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Show more ▾ Letrozole is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Letrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. A triazole and benzonitrile derivative that is a selective non-steroidal aromatase inhibitor, similar to ANASTROZOLE. It is used in the treatment of metastatic or locally advanced breast cancer in postmenopausal women. In 2023, this provider wrote 31 Medicare prescriptions for Letrozole, about 65% of the volume of the typical New York prescriber of this medication (48). Medicare paid an average of $24.56 per fill, versus $29.75 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 75 30-Day Fills standardized to 30-day supplies 2,250 Days of Medication total across all patients in 2023 | |||
| XareltoRivaroxaban | 28 | $839.63▼ below NY avg | ▼ Less than typical |
About Xarelto: Rivaroxaban is used to prevent blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip or knee replacement surgery. Show more ▾ It is also used to prevent blood clots from forming in high-risk patients with limited mobility during their hospital stay and after discharge. In addition, rivaroxaban is used to treat blood clots (such as in deep vein thrombosis-DVT or pulmonary embolus-PE) and to prevent the blood clots from forming again. Rivaroxaban may be used in children to prevent blood clots from forming after a certain heart surgery (Fontan procedure). Rivaroxaban is an anticoagulant that works by blocking certain clotting proteins in your blood. A morpholine and thiophene derivative that functions as a FACTOR XA INHIBITOR and is used in the treatment and prevention of DEEP-VEIN THROMBOSIS and PULMONARY EMBOLISM. It is also used for the prevention of STROKE and systemic embolization in patients with non-valvular ATRIAL FIBRILLATION, and for the prevention of atherothrombotic events in patients after an ACUTE CORONARY SYNDROME. In 2023, this provider wrote 28 Medicare prescriptions for Xarelto, about 64% of the volume of the typical New York prescriber of this medication (44). Medicare paid an average of $839.63 per fill, versus $894.03 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 42 30-Day Fills standardized to 30-day supplies 1,260 Days of Medication total across all patients in 2023 | |||
| RetacritEpoetin Alfa-Epbx | 25 | $592.17▼ below NY avg | ≈ Typical |
About Retacrit: This medication is used to treat anemia (low red blood cell count) in people with long-term serious kidney disease (chronic kidney failure), people receiving zidovudine to treat HIV, and people receiving chemotherapy for some types of cancer (cancer that does Show more ▾ not involve the bone marrow or blood cells). It may also be used in anemic patients to reduce the need for blood transfusions before certain planned surgeries that have a high risk of blood loss (usually given with an anticoagulant/blood thinner medication such as warfarin to lower the risk of serious blood clots). Epoetin alfa works by signaling the bone marrow to make more red blood cells. This medication is very similar to the natural substance in your body (erythropoietin) that prevents anemia. This monograph is about the following epoetin alfa products: epoetin alfa and epoetin alfa-epbx. In 2023, this provider wrote 25 Medicare prescriptions for Retacrit, about 89% of the volume of the typical New York prescriber of this medication (28). Medicare paid an average of $592.17 per fill, versus $692.27 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 25 30-Day Fills standardized to 30-day supplies 497 Days of Medication total across all patients in 2023 | |||
| Allopurinol | 25 | $9.71▼ below NY avg | ▼ Less than typical |
About Allopurinol: Allopurinol is used to treat gout and certain types of kidney stones. Show more ▾ It is also used to prevent increased uric acid levels in patients receiving cancer chemotherapy. These patients can have increased uric acid levels due to release of uric acid from the dying cancer cells. Allopurinol works by reducing the amount of uric acid made by the body. Increased uric acid levels can cause gout and kidney problems. A XANTHINE OXIDASE inhibitor that decreases URIC ACID production. It also acts as an antimetabolite on some simpler organisms. In 2023, this provider wrote 25 Medicare prescriptions for Allopurinol, about half the volume of the typical New York prescriber of this medication (44). Medicare paid an average of $9.71 per fill, versus $14.64 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 39 30-Day Fills standardized to 30-day supplies 1,170 Days of Medication total across all patients in 2023 | |||
| RevlimidLenalidomide | 22 | $19,042.81 | ▼ Less than typical |
About Revlimid: Lenalidomide is used to treat various types of cancers. Show more ▾ It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders (myelodysplastic syndromes-MDS). Lenalidomide may lessen the need for blood transfusions. Lenalidomide is not recommended for the treatment of a certain type of cancer (chronic lymphocytic leukemia) because of the increased risk of serious heart-related side effects and death. If you have this type of cancer, talk to your doctor about the risks of using this medication. A phthalimide and piperidone derivative that has immunomodulatory and antiangiogenic properties. It is used for the treatment of transfusion-dependent anemia in MYELODYSPLASTIC SYNDROMES, and for the treatment of MULTIPLE MYELOMA, and relapsed or refractory MANTLE CELL LYMPHOMA. In 2023, this provider wrote 22 Medicare prescriptions for Revlimid, about half the volume of the typical New York prescriber of this medication (41). Medicare paid an average of $19,042.81 per fill, versus $18,578.11 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 22 30-Day Fills standardized to 30-day supplies 602 Days of Medication total across all patients in 2023 | |||
| Ondansetron OdtOndansetron | 22 | $18.58▼ below NY avg | ≈ Typical |
About Ondansetron Odt: This medication is used alone or with other medications to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy) and radiation therapy. Show more ▾ It is also used to prevent and treat nausea and vomiting after surgery. Ondansetron works by blocking one of the body's natural substances (serotonin) that causes vomiting. A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties. In 2023, this provider wrote 22 Medicare prescriptions for Ondansetron Odt, about the same volume as the typical New York prescriber of this medication (21). Medicare paid an average of $18.58 per fill, versus $25.55 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 22 30-Day Fills standardized to 30-day supplies 336 Days of Medication total across all patients in 2023 | |||
| Zoledronic Acid | 22 | $249.58 | ▲ More than typical |
About Zoledronic Acid: This medication is used to treat high blood calcium levels (hypercalcemia) that may occur with cancer. Show more ▾ Zoledronic acid is also used with cancer chemotherapy to treat bone problems that may occur with multiple myeloma and other types of cancer (such as breast, lung) that have spread to the bones. Zoledronic acid belongs to a class of drugs known as bisphosphonates. It lowers high blood calcium levels by reducing the amount of calcium released from your bones into your blood. It also works by slowing the breakdown of your bones by cancer to prevent bone fractures. An imidobisphosphonate inhibitor of BONE RESORPTION that is used for the treatment of malignancy-related HYPERCALCEMIA; OSTEITIS DEFORMANS; and OSTEOPOROSIS. In 2023, this provider wrote 22 Medicare prescriptions for Zoledronic Acid, about 2 times the volume of the typical New York prescriber of this medication (11). Medicare paid an average of $249.58 per fill, versus $128.97 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 31 30-Day Fills standardized to 30-day supplies 896 Days of Medication total across all patients in 2023 | |||
| Lenalidomide | 21 | $14,268.09▼ below NY avg | ≈ Typical |
About Lenalidomide: Lenalidomide is used to treat various types of cancers. Show more ▾ It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders (myelodysplastic syndromes-MDS). Lenalidomide may lessen the need for blood transfusions. Lenalidomide is not recommended for the treatment of a certain type of cancer (chronic lymphocytic leukemia) because of the increased risk of serious heart-related side effects and death. If you have this type of cancer, talk to your doctor about the risks of using this medication. A phthalimide and piperidone derivative that has immunomodulatory and antiangiogenic properties. It is used for the treatment of transfusion-dependent anemia in MYELODYSPLASTIC SYNDROMES, and for the treatment of MULTIPLE MYELOMA, and relapsed or refractory MANTLE CELL LYMPHOMA. In 2023, this provider wrote 21 Medicare prescriptions for Lenalidomide, about the same volume as the typical New York prescriber of this medication (20). Medicare paid an average of $14,268.09 per fill, versus $14,905.13 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 21 30-Day Fills standardized to 30-day supplies 588 Days of Medication total across all patients in 2023 | |||
| Palonosetron Hcl | 21 | $92.36▼ below NY avg | ▼ Less than typical |
About Palonosetron Hcl: This medication is used to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy). Show more ▾ It is also used to prevent nausea and vomiting after surgery. Palonosetron works by blocking one of the body's natural substances (serotonin) that causes vomiting. In 2023, this provider wrote 21 Medicare prescriptions for Palonosetron Hcl, about half the volume of the typical New York prescriber of this medication (46). Medicare paid an average of $92.36 per fill, versus $185.72 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 21 30-Day Fills standardized to 30-day supplies 497 Days of Medication total across all patients in 2023 | |||
| Gabapentin | 21 | $8.02▼ below NY avg | ▼ Less than typical |
About Gabapentin: Gabapentin is used with other medications to prevent and control seizures. Show more ▾ It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug. A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME. In 2023, this provider wrote 21 Medicare prescriptions for Gabapentin, about a quarter of the volume of the typical New York prescriber of this medication (78). Medicare paid an average of $8.02 per fill, versus $17.62 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 23 30-Day Fills standardized to 30-day supplies 660 Days of Medication total across all patients in 2023 | |||
| Dexamethasone | 19 | $15.97▼ below NY avg | ▼ Less than typical |
About Dexamethasone: Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions, skin diseases, eye problems, breathing problems, bowel disorders, cancer, and immune system disorders. Show more ▾ It is also used as a test for an adrenal gland disorder (Cushing's syndrome). Dexamethasone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. An anti-inflammatory 9-fluoro-glucocorticoid. In 2023, this provider wrote 19 Medicare prescriptions for Dexamethasone, about 73% of the volume of the typical New York prescriber of this medication (26). Medicare paid an average of $15.97 per fill, versus $16.95 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 22.8 30-Day Fills standardized to 30-day supplies 490 Days of Medication total across all patients in 2023 | |||
| Furosemide | 19 | $1.81▼ below NY avg | ▼ Less than typical |
About Furosemide: Furosemide is used to reduce extra fluid in the body (edema) caused by conditions such as heart failure, liver disease, and kidney disease. Show more ▾ This can lessen symptoms such as shortness of breath and swelling in your arms, legs, and abdomen. This drug is also used to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Furosemide is a water pill (diuretic) that causes you to make more urine. This helps your body get rid of extra water and salt. A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY. In 2023, this provider wrote 19 Medicare prescriptions for Furosemide, about a quarter of the volume of the typical New York prescriber of this medication (72). Medicare paid an average of $1.81 per fill, versus $6.06 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 19 30-Day Fills standardized to 30-day supplies 570 Days of Medication total across all patients in 2023 | |||
| Lupron DepotLeuprolide Acetate | 18 | $5,589.08 | ▼ Less than typical |
About Lupron Depot: Leuprolide is used to treat advanced prostate cancer. Show more ▾ It is not a cure. Most types of prostate cancer need the hormone testosterone to grow and spread. Leuprolide works by reducing the amount of testosterone that the body makes. This helps slow or stop the growth of cancer cells and helps relieve symptoms such as painful/difficult urination. Talk to your doctor about the risks and benefits of treatment. A potent synthetic long-acting agonist of GONADOTROPIN-RELEASING HORMONE that regulates the synthesis and release of pituitary gonadotropins, LUTEINIZING HORMONE and FOLLICLE STIMULATING HORMONE. In 2023, this provider wrote 18 Medicare prescriptions for Lupron Depot, about half the volume of the typical New York prescriber of this medication (36). Medicare paid an average of $5,589.08 per fill, versus $4,960.47 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 53 30-Day Fills standardized to 30-day supplies 1,590 Days of Medication total across all patients in 2023 | |||
| Hydroxyurea | 18 | $33.66 | ▼ Less than typical |
About Hydroxyurea: This medication is used by people with sickle cell anemia to reduce the number of painful crises caused by the disease and to reduce the need for blood transfusions. Show more ▾ Some brands are also used to treat certain types of cancer (such as chronic myelogenous leukemia, squamous cell carcinomas). An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase. In 2023, this provider wrote 18 Medicare prescriptions for Hydroxyurea, about half the volume of the typical New York prescriber of this medication (34). Medicare paid an average of $33.66 per fill, versus $32.36 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 42.3 30-Day Fills standardized to 30-day supplies 1,270 Days of Medication total across all patients in 2023 | |||
| XtandiEnzalutamide | 17 | $13,222.31 | ▼ Less than typical |
About Xtandi: Enzalutamide is used to treat prostate cancer. Show more ▾ This medication belongs to a class of drugs known as anti-androgens (anti-testosterone). It works by blocking the effects of testosterone to slow the growth and spread of prostate cancer. In 2023, this provider wrote 17 Medicare prescriptions for Xtandi, about half the volume of the typical New York prescriber of this medication (31). Medicare paid an average of $13,222.31 per fill, versus $13,202.61 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 17 30-Day Fills standardized to 30-day supplies 510 Days of Medication total across all patients in 2023 | |||
| Exemestane | 17 | $227.05▼ below NY avg | ▼ Less than typical |
About Exemestane: This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Show more ▾ Exemestane is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Exemestane decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. Exemestane is usually not used in women of childbearing age. In 2023, this provider wrote 17 Medicare prescriptions for Exemestane, about half the volume of the typical New York prescriber of this medication (32). Medicare paid an average of $227.05 per fill, versus $280.23 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 39 30-Day Fills standardized to 30-day supplies 1,170 Days of Medication total across all patients in 2023 | |||
| Fosaprepitant Dimeglumine | 16 | $352.63 | ≈ Typical |
About Fosaprepitant Dimeglumine: Fosaprepitant is used with other medications to help prevent nausea and vomiting caused by cancer drug treatment (chemotherapy). Show more ▾ Fosaprepitant works by blocking one of the body's natural substances (substance P/neurokinin 1) that causes vomiting. This medication will not treat nausea or vomiting that has already started. Ask your doctor what you should do if you already have nausea or vomiting. In 2023, this provider wrote 16 Medicare prescriptions for Fosaprepitant Dimeglumine, about the same volume as the typical New York prescriber of this medication (14). Medicare paid an average of $352.63 per fill, versus $185.85 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 16 30-Day Fills standardized to 30-day supplies 392 Days of Medication total across all patients in 2023 | |||
| ProliaDenosumab | 16 | $1,640.05 | ▼ Less than typical |
About Prolia: Denosumab is used to treat bone loss (osteoporosis) in people who have a high risk of getting fractures. Show more ▾ Osteoporosis causes bones to become thinner and break more easily. Your chance of developing osteoporosis increases after menopause (in women), as you age, if someone in your family has osteoporosis, or if you take certain medications (such as prednisone) for long periods. This medication works by slowing bone loss to help maintain strong bones and reduce the risk of broken bones (fractures). Denosumab belongs to a class of drugs called monoclonal antibodies. It prevents certain cells in the body (osteoclasts) from breaking down bone. A humanized monoclonal antibody and an inhibitor of the RANK LIGAND, which regulates OSTEOCLAST differentiation and bone remodeling. It is used as a BONE DENSITY CONSERVATION AGENT in the treatment of OSTEOPOROSIS. In 2023, this provider wrote 16 Medicare prescriptions for Prolia, about half the volume of the typical New York prescriber of this medication (33). Medicare paid an average of $1,640.05 per fill, versus $1,534.91 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 95.6 30-Day Fills standardized to 30-day supplies 2,868 Days of Medication total across all patients in 2023 | |||
| Bortezomib | 15 | $2,843.12▼ below NY avg | ≈ Typical |
About Bortezomib: This medication is used to treat certain types of cancer (such as multiple myeloma, mantle cell lymphoma). Show more ▾ It works by slowing or stopping the growth of cancer cells. A pyrazine and boronic acid derivative that functions as a reversible PROTEASOME INHIBITOR. It is used as an ANTINEOPLASTIC AGENT in the treatment of MULTIPLE MYELOMA and MANTLE CELL LYMPHOMA. In 2023, this provider wrote 15 Medicare prescriptions for Bortezomib, about 75% of the volume of the typical New York prescriber of this medication (20). Medicare paid an average of $2,843.12 per fill, versus $3,045.69 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 15 30-Day Fills standardized to 30-day supplies 392 Days of Medication total across all patients in 2023 | |||
| Acyclovir | 14 | $6.68▼ below NY avg | ▼ Less than typical |
About Acyclovir: Acyclovir is used to treat infections caused by certain types of viruses. Show more ▾ It treats cold sores around the mouth (caused by herpes simplex), shingles (caused by herpes zoster), and chickenpox. This medication is also used to treat outbreaks of genital herpes. In people with frequent outbreaks, acyclovir is used to help reduce the number of future episodes. Acyclovir is an antiviral drug. However, it is not a cure for these infections. The viruses that cause these infections continue to live in the body even between outbreaks. Acyclovir decreases the severity and length of these outbreaks. It helps the sores heal faster, keeps new sores from forming, and decreases pain/itching. This medication may also help reduce how long pain remains after the sores heal. In addition, in people with a weakened immune system, acyclovir can decrease the risk of the virus spreading to other parts of the body and causing serious infections. A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes. In 2023, this provider wrote 14 Medicare prescriptions for Acyclovir, about half the volume of the typical New York prescriber of this medication (27). Medicare paid an average of $6.68 per fill, versus $49.10 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 19 30-Day Fills standardized to 30-day supplies 528 Days of Medication total across all patients in 2023 | |||
| Levofloxacin | 12 | $6.41▼ below NY avg | ▼ Less than typical |
About Levofloxacin: This medication is used to treat a variety of bacterial infections. Show more ▾ Levofloxacin belongs to a class of drugs known as quinolone antibiotics. It works by stopping the growth of bacteria. Levofloxacin injection is used if you cannot take the medication by mouth. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. The L-isomer of Ofloxacin. In 2023, this provider wrote 12 Medicare prescriptions for Levofloxacin, about half the volume of the typical New York prescriber of this medication (26). Medicare paid an average of $6.41 per fill, versus $8.82 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 12 30-Day Fills standardized to 30-day supplies 101 Days of Medication total across all patients in 2023 | |||
| Tramadol Hcl | 12 | $4.40▼ below NY avg | ▼ Less than typical |
About Tramadol Hcl: See also Warning section. Show more ▾ This medication is used to help relieve moderate to moderately severe pain. Tramadol belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. A narcotic analgesic proposed for severe pain. It may be habituating. In 2023, this provider wrote 12 Medicare prescriptions for Tramadol Hcl, about a third of the volume of the typical New York prescriber of this medication (39). Medicare paid an average of $4.40 per fill, versus $7.95 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 12 30-Day Fills standardized to 30-day supplies 266 Days of Medication total across all patients in 2023 | |||
| Prochlorperazine Maleate | 11 | $11.26▼ below NY avg | ▼ Less than typical |
About Prochlorperazine Maleate: This medication is used to treat severe nausea and vomiting from certain causes (for example, after surgery or cancer treatment). Show more ▾ Prochlorperazine belongs to a class of drugs known as phenothiazines. This medication is not recommended for use in children younger than 2 years or in children going through surgery. A phenothiazine antipsychotic used principally in the treatment of NAUSEA; VOMITING; and VERTIGO. It is more likely than CHLORPROMAZINE to cause EXTRAPYRAMIDAL DISORDERS. (From Martindale, The Extra Pharmacopoeia, 30th ed, p612) In 2023, this provider wrote 11 Medicare prescriptions for Prochlorperazine Maleate, about half the volume of the typical New York prescriber of this medication (26). Medicare paid an average of $11.26 per fill, versus $19.87 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 11 30-Day Fills standardized to 30-day supplies 112 Days of Medication total across all patients in 2023 | |||
| Somatuline DepotLanreotide Acetate | 11 | $8,733.06▼ below NY avg | ▼ Less than typical |
About Somatuline Depot: This medication is a long-acting form of lanreotide. Show more ▾ Lanreotide is used to treat a condition called acromegaly that occurs when the body makes too much of a certain natural substance called growth hormone. It is used when surgery or radiation treatment have not been fully successful or cannot be used. Treating acromegaly helps reduce the risk of serious problems such as diabetes and heart disease. Lanreotide works by decreasing the amount of growth hormone to normal levels. This drug is not a cure for acromegaly. It is used for the long-term treatment of this condition. This medication is also used to treat certain cancer or tumors of the stomach, intestines, or pancreas. It may help to slow down the growth of these tumors. Lanreotide is also used to treat carcinoid syndrome. It may help reduce the need to use another medication to treat diarrhea or flushing caused by carcinoid syndrome. In 2023, this provider wrote 11 Medicare prescriptions for Somatuline Depot, about half the volume of the typical New York prescriber of this medication (24). Medicare paid an average of $8,733.06 per fill, versus $9,745.12 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 11 30-Day Fills standardized to 30-day supplies 308 Days of Medication total across all patients in 2023 | |||
| Enoxaparin Sodium | 11 | $426.07 | ▼ Less than typical |
About Enoxaparin Sodium: Enoxaparin is used to prevent and treat harmful blood clots. Show more ▾ This helps to reduce the risk of a stroke or heart attack. This medication helps keep your blood flowing smoothly by lowering the activity of clotting proteins in the blood. Enoxaparin is an anticoagulant, also known as a blood thinner. It is a type of heparin. Conditions which increase your risk of developing blood clots include certain types of surgeries (such as knee/hip replacement, abdominal), long periods of being immobile, certain types of heart attack, and a specific type of chest pain called unstable angina. For some medical conditions, enoxaparin may be used in combination with other blood thinners. In 2023, this provider wrote 11 Medicare prescriptions for Enoxaparin Sodium, about half the volume of the typical New York prescriber of this medication (25). Medicare paid an average of $426.07 per fill, versus $161.72 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 11 30-Day Fills standardized to 30-day supplies 239 Days of Medication total across all patients in 2023 | |||
| Potassium Chloride | 11 | $35.96 | ▼ Less than typical |
About Potassium Chloride: This medication is a mineral supplement used to treat or prevent low amounts of potassium in the blood. Show more ▾ A normal level of potassium in the blood is important. Potassium helps your cells, kidneys, heart, muscles, and nerves work properly. Most people get enough potassium by eating a well-balanced diet. Some conditions that can lower your body's potassium level include severe prolonged diarrhea and vomiting, hormone problems such as hyperaldosteronism, or treatment with water pills/diuretics. A white crystal or crystalline powder used in BUFFERS; FERTILIZERS; and EXPLOSIVES. It can be used to replenish ELECTROLYTES and restore WATER-ELECTROLYTE BALANCE in treating HYPOKALEMIA. In 2023, this provider wrote 11 Medicare prescriptions for Potassium Chloride, about a quarter of the volume of the typical New York prescriber of this medication (46). Medicare paid an average of $35.96 per fill, versus $32.56 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 11 30-Day Fills standardized to 30-day supplies 219 Days of Medication total across all patients in 2023 | |||
| NeulastaPegfilgrastim | 11 | $9,401.51 | ▼ Less than typical |
About Neulasta: Pegfilgrastim is a man-made version of a certain natural substance made by your body. Show more ▾ It is used to help your body make more white blood cells. White blood cells are important to help you fight off infections. Pegfilgrastim is given to people whose ability to make white blood cells is reduced due to chemotherapy. Some brands may also be used to increase white blood cells after exposure to large amounts of radiation. This monograph is about the following pegfilgrastim products: pegfilgrastim, pegfilgrastim-apgf, pegfilgrastim-cbqv, pegfilgrastim-jmdb, pegfilgrastim-bmez, pegfilgrastim-fpgk, and pegfilgrastim-pbbk. In 2023, this provider wrote 11 Medicare prescriptions for Neulasta, about half the volume of the typical New York prescriber of this medication (19). Medicare paid an average of $9,401.51 per fill, versus $9,152.65 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 11 30-Day Fills standardized to 30-day supplies 259 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for MS. NOLYN C NYATANGA DO is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Medical Oncology prescribing approach at this Valley Stream, NY practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among NY prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
